Gene-expression profiling to classify soft-tissue sarcomas.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  The Lancet

• Publication date

  2002-04-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(02)08281-8PMID 11965266
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.

  2002cited by this paper
• Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study.

  2001cited by this paper
• c-KIT and c-KIT ligand (SCF) in synovial sarcoma (SS): an mRNA expression analysis in 23 cases

  2001cited by this paper
• Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification.

  2001cited by this paper
• Gastrointestinal stromal tumors with KIT mutations exhibit a remarkably homogeneous gene expression profile.

  2001cited by this paper
• KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.

  2001cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.

  1999cited by this paper

• NG2 expression predicts the metastasis formation in soft‐tissue sarcoma patients

  2009cites this paper
• [Metastasis to descending colon of an epididymal malignant fibrous histiocytoma].

  2009cites this paper
• Selecting the Right Targets for Cancer Therapy

  2008cites this paper
• Altered expression of urokinase-type plasminogen activator and plasminogen activator inhibitor in high-risk soft tissue sarcomas.

  2007cites this paper
• Controversies in Surgical Oncology: Routine Anthracycline-based Adjuvant Chemotherapy for Stage III Extremity Soft Tissue Sarcoma

  2007cites this paper
• The yin and yang of cancer therapeutics.

  2005cites this paper
• Molecular prognostication for soft tissue sarcomas: are we ready yet?

  2004cites this paper
• Statistical approach to DNA chip analysis.

  2003cites this paper